Human papillomavirus type 16-specific T cell responses and their association with recurrence of cervical disease following treatment

References

1. Altmann A., Jochmus-Kudielka I., Frank R., Gausepohl H., Moebius U., Gissmann L., Meuer S. C. 1992; Definition of immunogenic determinants of the human papillomavirus type-16 nucleoprotein-E7. Eur J Cancer 28A:326–333
   [Google Scholar]
2. De Gruijl T. D., Bontkes H. J. Walboomers., M J. M. 9 other authors 1996; Analysis of IgG reactivity against human papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: results of a prospective study. Int J Cancer 68:731–738
   [Google Scholar]
3. De Gruijl T. D., Bontkes H. J. Walboomers., M J. M. 9 other authors 1998; Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal study. Cancer Res 58:1700–1706
   [Google Scholar]
4. De Gruijl T. D., Bontkes H. J. Walboomers., M J. M. 10 other authors 1999; Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia I: differential T-helper and IgG responses in relation to HPV infection and disease outcome. J Gen Virol 80:399–408
   [Google Scholar]
5. Gill D. K., Bible J. M., Biswas C., Kell B., Best J. M., Punchard N. A., Cason J. 1998; Proliferative T-cell responses to human papillomavirus type 16 E5 are decreased amongst women with high-grade neoplasia. J Gen Virol 79:1971–1976
   [Google Scholar]
6. Kadish A. S., Romney S. L., Ledwidge R., Tindle R., Fernando G. J. P., Zee S. Y., Van Ranst M. A., Burk R. D. 1994; Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific. J Gen Virol 75:2277–2284
   [Google Scholar]
7. Kadish A. S., Ho G. Y. F., Burk R. D., Wang Y. X., Romney S. L., Ledwidge R., Angeletti R. H. 1997; Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia. J Natl Cancer Inst 89:1285–1293
   [Google Scholar]
8. Luxton J. C., Rowe A. J., Cridland J. C., Coletart T., Wilson P., Shepherd P. S. 1996; Proliferative T cell responses to the human papillomavirus type 16 E7 protein in women with cervical dysplasia and cervical carcinoma and in healthy individuals. J Gen Virol 77:1585–1593
   [Google Scholar]
9. Luxton J. C., Rose R. C., Coletart T., Wilson P., Shepherd P. S. 1997; Serological responses to human papillomavirus type 16 L1 virus-like particles in women with cervical disease and in healthy controls. J Gen Virol 78:917–923
   [Google Scholar]
10. Nakagawa M., Stites D. P., Farhat S., Judd A., Moscicki A. B., Canchola A. J., Hilton J. F., Palefsky J. M. 1996; T-cell proliferative response to human papillomavirus type 16 peptides: relationship to cervical intraepithelial neoplasia. Clin Diagn Lab Immunol 3:205–210
    [Google Scholar]
11. Shepherd P., Rowe A., Cridland J., Chapman M., Luxton J., Rayfield L. 1994; An immunodominant region in HPV-16 L1 identified by T cell responses in patients with cervical dysplasias. In Immunology of Human Papillomaviruses ( HPVs) pp  233–241 Edited by Stanley M. Cambridge: Cambridge University Press;
    [Google Scholar]
12. Shepherd P. S., Rowe A. J., Cridland J. C., Coletart T., Wilson P., Luxton J. C. 1996; Proliferative T cell responses to human papillomavirus type 16 L1 peptides in patients with cervical dysplasia. J Gen Virol 77:593–602
    [Google Scholar]
13. Strang G., Hickling J. K., Angus G., McIndoe J., Howland K., Wilkinson D., Ikeda H., Rothbard J. B. 1990; Human T cell responses to human papillomavirus type 16 L1 and E6 synthetic peptides: identification of T cell determinants, HLA-DR restriction and virus type specificity. J Gen Virol 71:423–431
    [Google Scholar]
14. Tsukui T., Hildesheim A., Schiffman M. H. 17 other authors 1996; Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Cancer Res 56:3967–3974
    [Google Scholar]